Intermediaries are negotiating good drug prices, but lack incentives to pass savings to beneficiaries and taxpayers
Intermediaries are negotiating good drug prices but lack the incentives to pass savings to beneficiaries and taxpayers, study finds
Jul 7, 2021
0
2